A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632, a strain with the ability to degrade purines

A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632, a strain with the ability to degrade purines

IntroductionHyperuricemia and gout are receiving an increasing scientific and medical attention because of their relatively high prevalence and their association with relevant co-morbidities. Recently, it has been suggested that gout patients have an altered gut microbiota. The first objective of th...

Full description

Bibliographic Details
Main Authors: Juan M. Rodríguez, Marco Garranzo, José Segura, Belén Orgaz, Rebeca Arroyo, Claudio Alba, David Beltrán, Leónides Fernández
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Microbiology
Subjects:
probiotics
Ligilactobacillus salivarius
gout
hyperuricemia
uric acid
inosine
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1111652/full

Similar Items

Similar Items